Form D · Biotechnology
Celmatix Inc.
New York, NY · CIK 0001514000
Offering snapshot reported Apr 1, 2016 · SEC filing
- Reported sold
- $4.8M Offering amount: $4.8M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 18, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 1, 2016 | Initial | $4,799,999 | No comparison | 1 | SEC filing |
| Sep 15, 2015 | Initial | $3,757,754 | No comparison | 5 | SEC filing |
| Jul 17, 2015 | Initial | $5,510,000 | No comparison | 6 | SEC filing |
| Feb 21, 2013 | Initial | $4,012,850 | No comparison | 13 | SEC filing |
| Mar 2, 2012 | Initial | $1,499,997 | No comparison | 10 | SEC filing |
| Feb 25, 2011 | Initial | $806,129 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-260502
Source: Form D, filed Apr 1, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Laura Bandak | Director |
| Piraye Yurttas Beim | Director, Executive |
| Steven J. Winick | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
14 Wall Street Suite 16 D
New York, NY, 10005
New York, NY, 10005